ArticleNeurology(R) neuroimmunology & neuroinflammation2023

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.

Alexandra Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.